Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in US

Massimiliano Povero, Lorenzo Pradelli

DOI: https://doi.org/10.7175/fe.v16i3.1200

Abstract

OBJECTIVES: High oxygen delivery (DO2) during cardiopulmonary bypass (CPB) is associated with better renal outcome
in cardiac surgery. Traditional perfusion (TP) techniques, targeted on body surface area and CPB temperature, achieves
high DO2 in about 50% of the cases while a goal directed perfusion (GDP) approach can lead to more than 90% of cases
achieving high DO2 with a consequent reduction in Acute Kidney Injury (AKI) rate of about 40%. Aim of this study is
to perform an economic evaluation of GDP strategy with respect to TP in US. METHODS: A Discrete Event Simulation
model was developed to compare TP and GDP strategy in patients undergoing CPB. The patient’s pathways from operation
to discharging from hospital was simulated: AKI incidence, in-hospital mortality, hospital length of stay, transfusions were
correlated to probability to achieve high DO2 target using published correlations. National perspective was adopted to calculate costs associated to each event while GDP strategy was exploited the introduction of Sorin Heartlink (HL) Card/GDP
Card and Sorin Connect (electronic data management system). RESULTS: GDP strategy saved more than 3 days in hospital
and 11% of AKI episodes. The cost-saving is $ 3,137 (95% CI: 1,122-4,951); the cost of HL Card/GDP Card+Connect ($
180, 95% CI: 113-249) is more than offset by savings in hospital stay that result the main driver in cost ($ 3,222, 95% CI:
1,235-4,950). Deterministic sensitivity analysis shows that the total savings are mainly influenced by nadir haematocrit
during CPB and hospital LOS/cost per day both in ICU and in ward. CONCLUSIONS: GDP seems to improve significantly
the main outcomes related to CPB surgery, when compared to TP techniques. Additional costs due to perform GDP strategy
have no impact on the total cost since completely offset by the savings in hospital cost.

Keywords

Cardiopulmonary bypass; Traditional perfusion; Goal directed perfusion

Full Text:

HTML PDF

References

  • de Somer F, Mulholland JW, Bryan MR, et al. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management? Crit Care 2011; 15: R192; http://dx.doi.org/10.1186/cc10349
  • Ranucci M, Romitti F, Isgrò G, et al. Oxygen delivery during cardiopolmunary bypass and acute renal failure after coronary operation. Ann Torac Surg 2005; 80: 2213-20; http://dx.doi.org710.1016/j.athoracsur.2015.02.034
  • The Goal dIrected perFusion Trial in Cardiac Surgery (GIFT). ClinicalTrials.gov Identifier:
  • NCT02250131
  • Habib R, Zacharias A, Schwann T, et al. Adverse effects on low hematocrit during cardiopulmonary bypass in the adult: Should current practice be change? J Thorac Cardiovasc Surg 2003; 125: 1438-50; http://dx.doi.org/10.1016/S0022-5223(02)73291-1
  • Karkouti K, Wikeysundera DN, Yau T et al. Acute Kidney Injury After Cardiac Surgery: Focus on Modifiable Risk Factors. Circulation 2009; 119: 495-502; http://dx.doi.org/10.1161/circulationaha.108.786913
  • Pradelli L, Zaniolo O. Perceval Sutureless valves in isolated and concomitant AVR procedures: an economic model shows overall decrease of costs for isolated or combined operations. Farmeconomia. Health economics and therapeutic pathways 2012; 13: 159-174; http://dx.doi.org/10.7175/fe.v13i4.282
  • Average Medicare Cost for AVR Patient. MedPar Report, 2013
  • Magnuson EA, Farkouh ME, Fuster V, et al. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease – Results from the FREEDOM trial. Circulation 2013; 127: 820-31; http://dx.doi.org/10.1161/CIRCULATIONAHA.112.147488
  • Eisenberg MH, Filion KB, Azoulay A, et al. Outcomes and cost of coronary artery bypass graft surgery in the United States and Canada. Arch Intern Med 2005; 165: 1506-13; http://dx.doi.org/10.1001/archinte.165.13.1506
  • Cowper PA, DeLong ER, Peterson ED, et al. Variability in cost of coronary bypass surgery in New York State: potential for cost savings. Am Heart J 2002; 143: 130-9; http://dx.doi.org/10.1067/mhj.2002.119617
  • Reynolds MR, Neil N, Ho KK, et al. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. Am Heart J 2003; 145: 334-42
  • Mehta RL, Kellum JA, Shah SV, et al. and the Acute Kidney Injury Network. Acute Kidney Injury Network: a report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31; http://dx.doi.org/10.1186/cc5713
  • Cockcroft D, Gault MD. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41; http://dx.doi.org/10.1159/000180580

Refbacks

  • There are currently no refbacks.




© SEEd srl